Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06285968 · ClinicalTrials.gov registry record · NA

The DREAM Study: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health

A NA study of Blood Pressure, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06285968: Recruiting NA study of Blood Pressure, sponsored by Columbia University.

NCT06285968 is a NA study of Blood Pressure that is actively recruiting participants, run by Columbia University. The registered enrollment target is 200 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06285968, a NA study of Blood Pressure, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized clinical trial is to evaluate the impact of a multidimensional sleep health promotion intervention on blood pressure, glycemic control indicators, anthropometric markers of adiposity, and lifestyle factors in adults. Participants will be randomized into an intervention or a control group. The control arm will receive standard Life's Essential 8 cardiovascular health educational materials. The intervention arm will additionally receive a multi-component intervention aimed at improving sleep health based on evidence-based sleep hygiene education and established behavior change techniques that include personalized sleep health feedback, goal setting and establishing a sleep health plan, coaching, self-monitoring, and addressing light and noise in the sleep environment. Mixed methods will be used to understand implementation determinants, processes, and outcomes, ensuring the successful completion and future expansion of this intervention.

Primary Outcome

The change office systolic blood pressure (mmHg) from baseline to follow-up at 8 weeks will be calculated and compared across randomization arms.

Conditions Studied

Interventions

  • BEHAVIORAL Multidimensional Sleep Health Promotion Intervention

Study Locations (1)

New York

  • Columbia University Irving Medical Center, Mailman School of Public Health - New York

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-03-12
Est. Completion 2027-03-31
Phase NA
Columbia University

958 total trials

What NCT06285968 shows while recruiting

NCT06285968 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (30% lower).

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Multidimensional Sleep Health Promotion Intervention is the first listed.

NCT06285968 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06285968 about?

NCT06285968 is a clinical study titled "The DREAM Study: A Multidimensional Sleep Health Intervention for Improving Cardiometabolic Health". The purpose of this randomized clinical trial is to evaluate the impact of a multidimensional sleep health promotion intervention on blood pressure, glycemic control indicators, anthropometric markers of adiposity, and lifestyle factors in adults. Participants will be randomized into an intervention...

What is the current status of trial NCT06285968?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-03-12. Estimated completion is 2027-03-31.

What conditions does trial NCT06285968 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT06285968?

The interventions under investigation include: Multidimensional Sleep Health Promotion Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06285968?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06285968 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06285968's enrollment target sits among peer trials

200 19th of 101 higher than 81 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06285968, the US trial registry maintained by the National Library of Medicine. NCT06285968 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.